The U.S. Marine Corps’ new Amphibious Combat Vehicles (ACVs) are redefining how America projects power from sea to shore. Built by BAE Systems to replace the Vietnam-era AAV-7, these next-generation ...

CNS-directed AAV gene therapy shows milder immune responses compared to systemic administration, reducing peripheral immune activation and systemic toxicities. Direct CNS delivery can bypass ...

Adeno-associated viruses (AAVs) are used in nearly a dozen FDA-approved therapies and more than 900 R&D projects to deliver therapeutic payloads to cells. Yet, large-scale AAV production is still a ...

The Marine Corps is pivoting back to the amphibious and fleet support roles that defined it during World War II. The US Marine Corps is moving on from the long-serving Assault Amphibious Vehicle (AAV) ...

Adeno-associated viruses (AAV) have emerged as pivotal delivery vehicles for gene therapy due to their overall safety (less immunogenic), efficiency (broad tropism), and long-term gene expression.